NVAX
Novavax Inc
Price:  
3.98 
USD
Volume:  
4,753,598.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Relative Valuation

-3249.2%
Upside

As of 2024-02-22, the Relative Valuation of Novavax Inc (NVAX) is (125.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.98 USD, the upside of Novavax Inc based on Relative Valuation is -3249.2%.

The range of the Relative Valuation is (132.89) - (116.81) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 28.8x - 32.6x 30.9x
Forward P/E multiples 21.7x - 25.3x 23.4x
Fair Price (132.89) - (116.81) (125.34)
Upside -3439.0% - -3035.0% -3249.2%
3.98 USD
Stock Price
(125.34) USD
Fair Price

Novavax Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 -0.86
2024-02-20 -0.89
2024-02-16 -0.90
2024-02-15 -0.93
2024-02-14 -0.89
2024-02-13 -0.84
2024-02-12 -0.90
2024-02-09 -0.87
2024-02-08 -0.82
2024-02-07 -0.82
2024-02-06 -0.85
2024-02-05 -0.81
2024-02-02 -0.85
2024-02-01 -0.87
2024-01-31 -0.87
2024-01-30 -0.87
2024-01-29 -0.91
2024-01-26 -0.88
2024-01-25 -0.89
2024-01-24 -0.88
2024-01-23 -0.92
2024-01-22 -0.90
2024-01-19 -0.88
2024-01-18 -0.89
2024-01-17 -0.91
2024-01-16 -0.94
2024-01-12 -0.99
2024-01-11 -0.99
2024-01-10 -1.05
2024-01-09 -1.04
2024-01-08 -1.11
2024-01-05 -1.08
2024-01-04 -1.12
2024-01-03 -1.06
2024-01-02 -1.09
2023-12-29 -1.04
2023-12-28 -1.06
2023-12-27 -1.07
2023-12-26 -1.09
2023-12-22 -1.10
2023-12-21 -1.07
2023-12-20 -1.06
2023-12-19 -1.13
2023-12-18 -1.12
2023-12-15 -1.17
2023-12-14 -1.23
2023-12-13 -1.16
2023-12-12 -1.15
2023-12-11 -1.20
2023-12-08 -1.21